InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Menzel Garry E, Chief Executive Officer. Insider active across 2 companies, notably TCR2 THERAPEUTICS INC.. In total, 10 reports have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €73k. Activity tracked since 31 August 2021. The latest transaction was filed on 10 July 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Menzel Garry E is Président et Directeur Général. He has filed 10 disclosures in total. Across the 10 sampled recent filings, covering the period from 2021-12-10 to 2023-07-10, there were EUR 72791 of sales and EUR 0 of purchases, and the most frequent transaction type is sale.